Browsing Category

Featured News

Articles Business C Suite On Deck disease Infographics Interviews Lifestyle

BioIntelliSense Joins Polaris Dawn Mission to Advance…

admin Nov 15, 2022 0

BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced its…

Articles

JellyFil Publishes Updated 2026 Product Information for Its Premium Gummy Dietary Supplement, Including Full Ingredient List, Pricing, Refund Policy, and Customer Service Details

2026-06-20T15:22:05Z

Florida-distributed gummy supplement brand details current ingredients, pricing, refund policy, and customer service processes for 2026

BreathEaseX Publishes Updated 2026 Product Information for Its Oral Spray Dietary Supplement, Including Full Ingredient List, Pricing, Refund Policy, and Customer Service Details

2026-06-20T02:01:02Z

Aurora, Colorado-based dietary supplement company refreshes publicly available product disclosures, reaffirms its 60-day money-back guarantee, and details current ordering, shipping, and support processes for 2026

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

2026-06-19T21:15:00Z

SAN CARLOS, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor...

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

2026-06-19T20:30:00Z

NOVATO, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases,...

Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 9, 2026

2026-06-19T20:30:00Z

REGULATED INFORMATIONJune 19, 2026, 10:30pm CET / 4:30pm ET

Dr. Austin Harris, MD Announces NAD+ IV Infusion Therapy Availability at NeuroRelief for Cellular Health and Cognitive Wellness Support in 2026

2026-06-19T20:05:17Z

SHERMAN OAKS, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Dr. Austin Harris, MD, founder of NeuroRelief Ketamine & Infusion Therapy, has announced the availability of NAD+ IV infusion therapy as...

CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2026-06-19T20:05:00Z

CAMBRIDGE, Mass., June 19, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate...

Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders

2026-06-19T20:02:58Z

VANCOUVER, British Columbia, June 19, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed...

Boston Dental Named The Best Dentist in Boston

2026-06-19T17:33:00Z

Prestigious Recognition Highlights Boston Dental's Commitment to Excellence in Dental and Aesthetic Services

Comprehensive Healthcare opens Columbia Valley Center for Recovery, the Tri-Cities' first inpatient behavioral health treatment and recovery facility

2026-06-19T16:00:00Z

YAKIMA, Wash., June 19, 2026 (GLOBE NEWSWIRE) -- Comprehensive Healthcare today announced that the Columbia Valley Center for Recovery (CVCR) in Kennewick will open on Saturday, June 20, marking an...

FDA Approves Labeled Strength Update of TWIRLA® (levonorgestrel/ethinyl estradiol) Birth Control Patch

2026-06-19T13:51:47Z

FLORHAM PARK, N.J., June 19, 2026 (GLOBE NEWSWIRE) -- Exeltis USA, Inc. (Exeltis), a global pharmaceutical company specializing in women’s health, announced that the U.S. Food and Drug Administration (FDA)...

Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam

2026-06-19T12:30:00Z

Panel to Address Litecoin's Institutional Evolution, Marking the First Time a Digital Asset Treasury Company Has Taken the Stage at the Litecoin Foundation's Annual Summit

Glass House Brands Announces Voting Results Following Annual Meeting

2026-06-19T11:30:00Z

LONG BEACH, Calif. and TORONTO, June 19, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (OTCQX: GLASF) today announced that, at the...

uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy

2026-06-19T11:05:00Z

~ AMT-260 was generally well-tolerated with no serious adverse events observed to date, with early biological signals of potential therapeutic activity ~

Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma

2026-06-19T10:31:15Z

Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma

Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026

2026-06-19T10:30:00Z

Global CRO expands its operational footprint into Singapore and Malaysia, strengthens China presence, and grows India operations - creating a powerhouse in the Asia Pacific region

Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026

2026-06-19T10:30:00Z

Global CRO expands its operational footprint into Singapore and Malaysia, strengthens China presence, and grows India operations - creating a powerhouse in the Asia Pacific region

The Ensign Group, Inc. Declares Quarterly Dividend of $0.0650 Per Share

2026-06-19T10:00:00Z

SAN JUAN CAPISTRANO, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled...

Arletta Pharma Solutions Appoints Steve van Os, MD, as Chief Medical Officer

2026-06-19T07:53:55Z

www.arlettapharmasolutions.com

Kither Biotech successfully completes Phase 1 clinical trial of KIT2014, a novel inhaled peptide therapy for respiratory diseases

2026-06-19T07:30:00Z

TURIN, Italy, June 19, 2026 (GLOBE NEWSWIRE) -- Kither Biotech Pty Ltd and Kither Biotech srl, a clinical-stage biopharmaceutical group of companies developing innovative therapies for respiratory diseases, today announced...

Professor Mohamed Shamji Assumes Presidency of EAACI as Congress 2026 Concludes in Istanbul

2026-06-19T07:00:00Z

New leadership begins as the global allergy community advances the Vision Zero ambition of a future free from allergy and asthma burden

MindMaze and Vibra Healthcare Partner to Deliver Advanced Digital Medicine and Neurorehabilitation Solutions for Patients from Clinic-to-Home

Vision Without Glasses: Advanced Eye Surgery Technologies Are Transforming Lives Across…

Surfacide® Expands UV-C Disinfection in All MedStar Hospitals in…

India’s Health Sector Accelerates Digital Transformation Amid Rising…

Featured News

BioIntelliSense Joins Polaris Dawn Mission to Advance…